| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |